Skip to the page

Data / Form D filings / Syenex, Inc.

Syenex, Inc.: Form D filings

Syenex, Inc., a biotechnology company in Evanston, IL, filed 3 Form D notices with the SEC between 2022 and 2025. The latest, on January 27, 2025, reports $8.7 million sold of a $8.7 million offering to 18 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1801 Maple Ave, Suite 6210, Evanston, IL, 60201
Phone
(914) 525-9068
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1935303

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 27, 2025New notice$8,662,428$8,662,42818Jan 13, 2025sec.gov
Sep 7, 2022Amendment$5,000,000$5,000,00014Jun 1, 2022sec.gov
Jul 13, 2022New notice$2,000,000$225,000$1,775,0004Jun 1, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
John D. RosanelliExecutive Officer, Director

Other biotechnology companies in Illinois that filed recently

Every Form D from the week of Jan 27, 2025 · All recent filings in Illinois · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Syenex, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.